These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5003834)

  • 1. [Cell-containing substrates and vaccine production].
    Majer M
    Schweiz Med Wochenschr; 1970 Nov; 100(48):2086-9. PubMed ID: 5003834
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of nonhuman primates for assaying tumorigenicity of viral-vaccine cell substrates.
    Petricciani JC; Martin DP
    Transplant Proc; 1974 Jun; 6(2):189-92. PubMed ID: 4208755
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of cell cultures in vaccine production: diploid and stable cell cultures.
    Matchett A
    J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue and medium antigens in vaccines.
    Coriell LL
    Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of standardized cell substrates as an alternative to primary animal tissue for vaccine production.
    Perkins FT
    Proc R Soc Med; 1970 Oct; 63(10):985-6. PubMed ID: 5483522
    [No Abstract]   [Full Text] [Related]  

  • 6. Tests for RNA tumor viruses in cell substrates used in virus vaccine production.
    Petricciani JC; Milstien JB
    Dev Biol Stand; 1976 Dec 13-15; 37():229-34. PubMed ID: 73485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suggested criteria for the acceptability of a passaged diploid cell population as substrate for virus vaccine production.
    Perkins FT
    Jpn J Med Sci Biol; 1971 Oct; 24(5):336-41. PubMed ID: 5003825
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoplastic properties of animal cell lines--general comments.
    Macpherson I
    Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of primary cultures and diploid cells--technology of production.
    Holper JC
    Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
    [No Abstract]   [Full Text] [Related]  

  • 10. New trends in the preparation of cell substrates for the production of virus vaccines.
    van Wezel AL
    Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell substrates for human virus vaccine preparation--general comments.
    Hayflick L
    Natl Cancer Inst Monogr; 1968 Dec; 29():83-91. PubMed ID: 5720814
    [No Abstract]   [Full Text] [Related]  

  • 12. Diploid cell lines from subhuman primates as substrates for virus vaccine production.
    Wallace RE; Vasington PJ; Petricciani JC; Hopps HE; Lorenz DE
    Prog Immunobiol Stand; 1971; 5():181-6. PubMed ID: 4633958
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell cultures for virus vaccine production. General conclusions from the conference.
    Merchant DJ
    Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on use of cell cultures in vaccine production.
    Kniazeff AJ
    J Am Vet Med Assoc; 1970 Jun; 156(12):1795-7. PubMed ID: 5422528
    [No Abstract]   [Full Text] [Related]  

  • 15. History of the acceptance of human diploid cell strains as substrates for human virus vaccine manufacture.
    Hayflick L; Plotkin S; Stevenson RE
    Dev Biol Stand; 1987; 68():9-17. PubMed ID: 3691964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of diploid cell lines as a multiplication substrate for viral vaccine production].
    Welke G
    Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of cell cultures in vaccine production: primary cell cultures.
    Smith KO
    J Am Vet Med Assoc; 1970 Jun; 156(12):1787-90. PubMed ID: 5463597
    [No Abstract]   [Full Text] [Related]  

  • 18. Suggested methods for the management and testing of a passaged diploid cell culture used for virus vaccine production.
    Perkins FT
    Jpn J Med Sci Biol; 1971 Oct; 24(5):342-4. PubMed ID: 5316784
    [No Abstract]   [Full Text] [Related]  

  • 19. The need for a standardised cell substrate for virus vaccine production.
    Perkins FT
    Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315
    [No Abstract]   [Full Text] [Related]  

  • 20. Cells, vaccines, and the pursuit of precedent.
    Hilleman MR
    Natl Cancer Inst Monogr; 1968 Dec; 29():463-9. PubMed ID: 4888933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.